FCN2
Basic information
Region (hg38): 9:134880810-134887523
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FCN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 23 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 2 | 6 |
Variants in FCN2
This is a list of pathogenic ClinVar variants found in the FCN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-134880832-A-T | Benign (Jul 21, 2017) | |||
9-134880844-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
9-134880854-C-T | Benign (Jul 21, 2017) | |||
9-134882543-C-G | not specified | Uncertain significance (Jun 09, 2022) | ||
9-134882550-G-T | not specified | Uncertain significance (Oct 06, 2021) | ||
9-134882582-C-A | not specified | Uncertain significance (May 13, 2024) | ||
9-134883307-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
9-134883308-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
9-134883353-A-G | not specified | Uncertain significance (Sep 19, 2022) | ||
9-134884761-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
9-134885242-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
9-134885244-C-T | Benign (Jul 21, 2017) | |||
9-134885254-A-G | Benign (Aug 01, 2024) | |||
9-134885274-C-T | Likely benign (Jul 01, 2023) | |||
9-134885320-C-A | not specified | Uncertain significance (Nov 08, 2022) | ||
9-134885343-G-C | not specified | Uncertain significance (Jul 14, 2023) | ||
9-134885350-A-G | not specified | Uncertain significance (Jan 23, 2023) | ||
9-134885352-G-A | not specified | Uncertain significance (Oct 24, 2023) | ||
9-134885372-T-C | Benign (Jul 21, 2017) | |||
9-134885807-C-T | not specified | Uncertain significance (May 15, 2023) | ||
9-134885812-C-A | not specified | Uncertain significance (Feb 14, 2024) | ||
9-134885816-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
9-134885837-G-A | not specified | Uncertain significance (Jul 19, 2022) | ||
9-134885853-A-T | not specified | Uncertain significance (Sep 22, 2022) | ||
9-134885882-G-T | not specified | Uncertain significance (Apr 13, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FCN2 | protein_coding | protein_coding | ENST00000291744 | 8 | 7271 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.56e-11 | 0.0485 | 125493 | 1 | 254 | 125748 | 0.00101 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.361 | 204 | 190 | 1.07 | 0.0000113 | 2009 |
Missense in Polyphen | 64 | 57.809 | 1.1071 | 694 | ||
Synonymous | -0.767 | 90 | 81.2 | 1.11 | 0.00000523 | 633 |
Loss of Function | -0.0309 | 16 | 15.9 | 1.01 | 9.52e-7 | 150 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00113 | 0.00111 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00740 | 0.00737 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000561 | 0.000545 |
Middle Eastern | 0.00740 | 0.00737 |
South Asian | 0.000863 | 0.000850 |
Other | 0.000988 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: May function in innate immunity through activation of the lectin complement pathway. Calcium-dependent and GlcNAc- binding lectin. Enhances phagocytosis of S.typhimurium by neutrophils, suggesting an opsonic effect via the collagen region. {ECO:0000269|PubMed:10679061, ECO:0000269|PubMed:17215869}.;
- Pathway
- Human Complement System;Innate Immune System;Immune System;Initial triggering of complement;Ficolins bind to repetitive carbohydrate structures on the target cell surface;Lectin pathway of complement activation;Creation of C4 and C2 activators;Complement cascade
(Consensus)
Recessive Scores
- pRec
- 0.0963
Intolerance Scores
- loftool
- 0.573
- rvis_EVS
- 0.58
- rvis_percentile_EVS
- 82.3
Haploinsufficiency Scores
- pHI
- 0.0980
- hipred
- N
- hipred_score
- 0.133
- ghis
- 0.436
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.421
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Fcnb
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- complement activation, lectin pathway;proteolysis;complement activation;opsonization;recognition of apoptotic cell;defense response to Gram-negative bacterium;defense response to Gram-positive bacterium
- Cellular component
- extracellular region;collagen trimer;extracellular exosome;blood microparticle
- Molecular function
- antigen binding;serine-type endopeptidase activity;protein binding;proteoglycan binding;metal ion binding;calcium-dependent protein binding;mannan binding